522 related articles for article (PubMed ID: 25364765)
1. Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseases.
Katoh M
Front Cell Dev Biol; 2014; 2():61. PubMed ID: 25364765
[TBL] [Abstract][Full Text] [Related]
2. Systematic analysis of berberine-induced signaling pathway between miRNA clusters and mRNAs and identification of mir-99a ∼ 125b cluster function by seed-targeting inhibitors in multiple myeloma cells.
Feng M; Luo X; Gu C; Li Y; Zhu X; Fei J
RNA Biol; 2015; 12(1):82-91. PubMed ID: 25826415
[TBL] [Abstract][Full Text] [Related]
3. miR-125b targets ARID3B in breast cancer cells.
Akhavantabasi S; Sapmaz A; Tuna S; Erson-Bensan AE
Cell Struct Funct; 2012; 37(1):27-38. PubMed ID: 22307404
[TBL] [Abstract][Full Text] [Related]
4. miRNA signature identification of retinoblastoma and the correlations between differentially expressed miRNAs during retinoblastoma progression.
Yang Y; Mei Q
Mol Vis; 2015; 21():1307-17. PubMed ID: 26730174
[TBL] [Abstract][Full Text] [Related]
5. miR-200a, miR-200b and miR-429 are onco-miRs that target the PTEN gene in endometrioid endometrial carcinoma.
Yoneyama K; Ishibashi O; Kawase R; Kurose K; Takeshita T
Anticancer Res; 2015 Mar; 35(3):1401-10. PubMed ID: 25750291
[TBL] [Abstract][Full Text] [Related]
6. Identification of MicroRNAs as Diagnostic Biomarkers for Breast Cancer Based on the Cancer Genome Atlas.
Kim J
Diagnostics (Basel); 2021 Jan; 11(1):. PubMed ID: 33440868
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
8. A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt signaling.
Wang DY; Gendoo DMA; Ben-David Y; Woodgett JR; Zacksenhaus E
Breast Cancer Res; 2019 Jan; 21(1):18. PubMed ID: 30704524
[TBL] [Abstract][Full Text] [Related]
9. A carvedilol-responsive microRNA, miR-125b-5p protects the heart from acute myocardial infarction by repressing pro-apoptotic bak1 and klf13 in cardiomyocytes.
Bayoumi AS; Park KM; Wang Y; Teoh JP; Aonuma T; Tang Y; Su H; Weintraub NL; Kim IM
J Mol Cell Cardiol; 2018 Jan; 114():72-82. PubMed ID: 29122578
[TBL] [Abstract][Full Text] [Related]
10. Good guy or bad guy: the opposing roles of microRNA 125b in cancer.
Banzhaf-Strathmann J; Edbauer D
Cell Commun Signal; 2014 Apr; 12():30. PubMed ID: 24774301
[TBL] [Abstract][Full Text] [Related]
11. miRNA and cancer; computational and experimental approaches.
Tutar Y
Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol and prostate cancer: promising role for microRNAs.
Dhar S; Hicks C; Levenson AS
Mol Nutr Food Res; 2011 Aug; 55(8):1219-29. PubMed ID: 21714127
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-elicited mesenchymal stem cell-derived exosomes facilitates cardiac repair through miR-125b-mediated prevention of cell death in myocardial infarction.
Zhu LP; Tian T; Wang JY; He JN; Chen T; Pan M; Xu L; Zhang HX; Qiu XT; Li CC; Wang KK; Shen H; Zhang GG; Bai YP
Theranostics; 2018; 8(22):6163-6177. PubMed ID: 30613290
[TBL] [Abstract][Full Text] [Related]
14. Elevated microRNA-125b levels predict a worse prognosis in HER2-positive breast cancer patients.
Luo Y; Wang X; Niu W; Wang H; Wen Q; Fan S; Zhao R; Li Z; Xiong W; Peng S; Zeng Z; Li X; Li G; Tan M; Zhou M
Oncol Lett; 2017 Feb; 13(2):867-874. PubMed ID: 28356971
[TBL] [Abstract][Full Text] [Related]
15. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
[TBL] [Abstract][Full Text] [Related]
18. The Potential Markers of Circulating microRNAs and long non-coding RNAs in Alzheimer's Disease.
Zhao Y; Zhang Y; Zhang L; Dong Y; Ji H; Shen L
Aging Dis; 2019 Dec; 10(6):1293-1301. PubMed ID: 31788340
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA expression profiles and type 1 diabetes mellitus: systematic review and bioinformatic analysis.
Assmann TS; Recamonde-Mendoza M; De Souza BM; Crispim D
Endocr Connect; 2017 Nov; 6(8):773-790. PubMed ID: 28986402
[TBL] [Abstract][Full Text] [Related]
20. CVD phenotyping in oncologic disorders: cardio-miRNAs as a potential target to improve individual outcomes in revers cardio-oncology.
Yang M; Li T; Guo S; Song K; Gong C; Huang N; Pang D; Xiao H
J Transl Med; 2024 Jan; 22(1):50. PubMed ID: 38216965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
